These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15647474)

  • 1. The micromolar zinc-binding domain on the NMDA receptor subunit NR2B.
    Rachline J; Perin-Dureau F; Le Goff A; Neyton J; Paoletti P
    J Neurosci; 2005 Jan; 25(2):308-17. PubMed ID: 15647474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
    Madry C; Mesic I; Betz H; Laube B
    Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
    Hatton CJ; Paoletti P
    Neuron; 2005 Apr; 46(2):261-74. PubMed ID: 15848804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
    Erreger K; Geballe MT; Kristensen A; Chen PE; Hansen KB; Lee CJ; Yuan H; Le P; Lyuboslavsky PN; Micale N; Jørgensen L; Clausen RP; Wyllie DJ; Snyder JP; Traynelis SF
    Mol Pharmacol; 2007 Oct; 72(4):907-20. PubMed ID: 17622578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors.
    Perin-Dureau F; Rachline J; Neyton J; Paoletti P
    J Neurosci; 2002 Jul; 22(14):5955-65. PubMed ID: 12122058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
    Laurie DJ; Seeburg PH
    Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of differential control of NMDA receptor activity by NR2 subunits.
    Gielen M; Siegler Retchless B; Mony L; Johnson JW; Paoletti P
    Nature; 2009 Jun; 459(7247):703-7. PubMed ID: 19404260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL; Barr BM
    J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of different competitive antagonists interaction with NR2A and NR2B subunits of N-methyl-D-aspartate (NMDA) ionotropic glutamate receptor.
    Blaise MC; Sowdhamini R; Pradhan N
    J Mol Model; 2005 Nov; 11(6):489-502. PubMed ID: 15928921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of the amino terminal domain in NMDA receptor modulation.
    Huggins DJ; Grant GH
    J Mol Graph Model; 2005 Jan; 23(4):381-8. PubMed ID: 15670959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determinants of multiple effects of nickel on NMDA receptor channels.
    Gavazzo P; Guida P; Zanardi I; Marchetti C
    Neurotox Res; 2009 Jan; 15(1):38-48. PubMed ID: 19384586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition.
    Chen N; Moshaver A; Raymond LA
    Mol Pharmacol; 1997 Jun; 51(6):1015-23. PubMed ID: 9187268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
    Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
    J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies.
    Ng FM; Geballe MT; Snyder JP; Traynelis SF; Low CM
    Mol Brain; 2008 Nov; 1():16. PubMed ID: 19017396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A.
    Zheng F; Erreger K; Low CM; Banke T; Lee CJ; Conn PJ; Traynelis SF
    Nat Neurosci; 2001 Sep; 4(9):894-901. PubMed ID: 11528420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition.
    Gielen M; Le Goff A; Stroebel D; Johnson JW; Neyton J; Paoletti P
    Neuron; 2008 Jan; 57(1):80-93. PubMed ID: 18184566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit.
    Paoletti P; Perin-Dureau F; Fayyazuddin A; Le Goff A; Callebaut I; Neyton J
    Neuron; 2000 Dec; 28(3):911-25. PubMed ID: 11163276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor.
    Han X; Tomitori H; Mizuno S; Higashi K; Füll C; Fukiwake T; Terui Y; Leewanich P; Nishimura K; Toida T; Williams K; Kashiwagi K; Igarashi K
    J Neurochem; 2008 Dec; 107(6):1566-77. PubMed ID: 19014388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
    Yuan H; Hansen KB; Vance KM; Ogden KK; Traynelis SF
    J Neurosci; 2009 Sep; 29(39):12045-58. PubMed ID: 19793963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.